US Stocks
/
Nuvation Bio Inc. Share Price

Nuvation Bio Inc. Share Price

NYSE: NUVB | Micro Cap
$6.61
+$0.00 (0.08%) Last updated on 11 Aug, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Nuvation Bio Inc. Stock Performance

Open
$6.60
Prev. Close
$6.61
Circuit Range
N/A
Day Range
$6.38 - $6.60
Year Range
$2.19 - $9.75
Volume
3,21,935
Average Traded
$6.52

Nuvation Bio Inc. Share Price Today

As of 11 August 2026, Nuvation Bio Inc.'s share price is $6.61. The stock opened at $6.60, compared to its previous close of $6.61. During today's trading session, Nuvation Bio Inc.'s share price traded between $6.38 and $6.60, with an average price of $6.49. Over the past 52 weeks, the stock has recorded a high of $9.75 and a low of $2.19. In terms of performance, Nuvation Bio Inc.'s share price has risen by 11.66% over the last six months and is up 122.18% on a year-on-year basis.

Nuvation Bio Inc. Share Price Chart

$6.38$6.60
L
Show Current Price
H

Nuvation Bio Inc. Stock Fundamentals & Key Indicators

Market Cap
$2.26M
PE Ratio (TTM)
-11.02
Dividend Yield
N/A
EPS (TTM)
$-0.60
Revenue (TTM)
$62.90M
Return On Equity (TTM)
-66.93%
Profit Margin
-325.31%
Debt to Equity
0.27
Quarterly Earnings Growth YoY
-35.38%

Nuvation Bio Inc. Quarterly Profit & Loss

All figures in USD

ParticularsJun 2024Sep 2024Mar 2025Jun 2025Sep 2025
Revenue$1.44M$727000.00$3.08M$4.83M$13.12M
Net Profit-$462.49M-$41.21M-$53.24M-$59.01M-$55.79M
Net Profit Margin-32229.41%-5668.50%-1726.20%-1220.92%-425.24%
Income ChangeN/A91.09%-29.18%-10.84%5.45%

Nuvation Bio Inc. Annual Profit & Loss

All figures in USD

Particulars2024
Revenue-$7.08M
Net Profit-$567.94M
Net Profit Margin8024.00%
Income ChangeN/A

About Nuvation Bio Inc.

Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutic candidates for oncology. Its lead product candidate is taletrectinib, an ROS1 inhibitor for the treatment of patients with ROS1+ non-small cell lung cancer. The company is also developing Safusidenib, an inhibitor of mutant isocitrate dehydrogenase 1 in phase 2 clinical trials; NUV-1511, a drug-drug conjugate for use in chemotherapy agent that suppresses the growth of various advanced solid tumors; and NUV-868, a binding domain 2 bromodomain and extra-terminal inhibitor that inhibits bromodomain-containing protein 4. The company was founded in 2018 and is headquartered in New York, New York.

Nuvation Bio Inc. Historical Returns

MonthOpenCloseChange %
Aug 2026
$6.27
$6.61
+4.34%
Jul 2026
$5.81
$6.33
+11.63%
Jun 2026
$4.75
$5.67
+18.97%
May 2026
$4.43
$4.77
+7.43%
Apr 2026
$4.40
$4.44
+3.74%
Mar 2026
$5.70
$4.28
-27.70%
Feb 2026
$5.24
$5.92
+12.55%
Jan 2026
$8.97
$5.26
-41.33%
Dec 2025
$7.92
$8.96
+11.66%
Nov 2025
$5.36
$8.03
+53.96%
Oct 2025
$3.74
$5.21
+41.14%
Sep 2025
$2.95
$3.69
+24.20%

NUVB Share Price FAQs

What is Nuvation Bio Inc. share price today?

chevron-up
Nuvation Bio Inc. share price today is $6.61 as on August 11, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Nuvation Bio Inc. stock?

chevron-up
The 52 week high of Nuvation Bio Inc. stock is $9.75, while the 52 week low is $2.19 as of 11 Aug '26.

What is NUVB's market capitalisation today?

chevron-up
NUVB market capitalisation is $2.26M as of August 11, 2026, at 7:33 am IST.

What is NUVB's net income for the last quarter?

chevron-up
NUVB's net income for the last quarter is -0.06B USD.

What is the 5 year returns of NUVB?

chevron-up
The 5 year returns of NUVB is -28.39% as on 11 Aug '26.

What is the high & low stock price of NUVB today?

chevron-up
NUVB stock price hit a high of $6.60 and low of $6.38 as of 11 Aug '26.

Can I buy NUVB shares in India?

chevron-up
Yes. You can buy NUVB in India by opening an international trading account.